Get the latest tech news
World’s 1st donor cell therapy helps 3 autoimmune disorder patients
The treatment, involving the use of donor cells, has shown positive results in patients six months after receiving treatment.
Allogeneic chimeric antigen receptor (CAR)-T cells hold great promise for expanding the accessibility of CAR-T therapy, whereas the risks of allograft rejection have hampered its application. Our results demonstrate the high safety and promising immune modulatory effect of the off-the-shelf CAR-T cells in treating severe refractory autoimmune diseases. Having contributed to renowned wire agencies and Indian media outlets like ANI and NDTV, he is keenly interested in Tech, Business and Defense coverage.
Or read this on r/tech
